Similar VLDL-TG storage in visceral and subcutaneous fat in obese and lean women

Diabetes. 2011 Nov;60(11):2787-91. doi: 10.2337/db11-0604. Epub 2011 Sep 12.

Abstract

Objective: Excess visceral fat accumulation is associated with the metabolic disturbances of obesity. Differential lipid redistribution through lipoproteins may affect body fat distribution. This is the first study to investigate VLDL-triglyceride (VLDL-TG) storage in visceral fat.

Research design and methods: Nine upper-body obese (UBO; waist circumference >88 cm) and six lean (waist circumference <80 cm) women scheduled for elective tubal ligation surgery were studied. VLDL-TG storage in visceral, upper-body subcutaneous (UBSQ), and lower-body subcutaneous (LBSQ) fat were measured with [9,10-(3)H]-triolein-labeled VLDL.

Results: VLDL-TG storage in visceral fat accounted for only ~0.8% of VLDL-TG turnover in UBO and lean women, respectively. A significantly larger proportion of VLDL-TG turnover was stored in UBSQ (~5%) and LBSQ (~4%) fat. The VLDL-TG fractional storage was similar in UBO and lean women for all regional depots. VLDL-TG fractional storage and VLDL-TG concentration were correlated in UBO women in UBSQ fat (r = 0.68, P = 0.04), whereas an inverse association was observed for lean women in visceral (r = -0.89, P = 0.02) and LBSQ (r = -0.87, P = 0.02) fat.

Conclusions: VLDL-TG storage efficiency is similar in all regional fat depots, and trafficking of VLDL-TG into different adipose tissue depots is similar in UBO and lean women. Postabsorptive VLDL-TG storage is unlikely to be of major importance in the development of preferential upper-body fat distribution in obese women.

Trial registration: ClinicalTrials.gov NCT00893893.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / pathology
  • Adiposity
  • Adult
  • Algorithms
  • Biopsy
  • Body Mass Index
  • Cell Size
  • Female
  • Humans
  • Intra-Abdominal Fat / metabolism*
  • Intra-Abdominal Fat / pathology
  • Kinetics
  • Lipoproteins, VLDL / blood
  • Lipoproteins, VLDL / metabolism*
  • Obesity / metabolism*
  • Obesity / pathology
  • Organ Specificity
  • Subcutaneous Fat / metabolism*
  • Subcutaneous Fat / pathology
  • Thorax / pathology
  • Triglycerides / blood
  • Triglycerides / metabolism*
  • Tritium
  • Waist Circumference

Substances

  • Lipoproteins, VLDL
  • Triglycerides
  • very low density lipoprotein triglyceride
  • Tritium

Associated data

  • ClinicalTrials.gov/NCT00893893